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 _____________________________________________________________________________________________________ 
rectal cancer, the clinical target volume was delineated and 
for breast cancer, the regional nodal areas (internal 
mammary, level I to IV axillary and Rotter space) were 
contoured. A trained radiation technologist then reviewed all 
cases according to the guidelines and feedback was given 
within 24 hours. Twenty-four departments participated to the 
study and in total more than 2200 contours were reviewed: 
over 1200 rectal cancer patients and over 1000 breast cancer 
patients.Evaluation of the contours showed that 74 % of 
rectal cancer cases were modified. These high numbers 
indicate that the interpretation of guidelines is not always 
straightforward. More important however is the learning 
curve that was achieved. The rectal overlap and volumetric 
parameters significantly increased between the first ten 
patients per center and others. The study of the contouring 
of the locoregional nodal delineation in breast cancer is still 
ongoing and first results will be presented at presented at 
the ESTRO 35. For both breast and rectal cancer, some 
deficiencies in the description of the guidelines were 
demonstrated, making the interpretation ambiguous, and the 
guidelines will be adapted accordingly. Within a national QA 
project, we have shown that clinical audit of target 
delineation improves the quality of the contouring: the inter-
observer variability and the major deviations from the 
guidelines are substantially reduced. Variability in anatomical 
contouring contributes to uncertainty in treatment planning 
and compromises the quality of the treatment plan and 
delivered treatment. The standardization of tumor and target 
volume contouring is therefore highly desirable and can be 
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Current plan generation is an iterative trial-and-error 
procedure in which the planner tries to steer the treatment 
planning system (TPS) towards an acceptable plan by 
tweaking of parameters, such as beam angles, goal functions 
or weights. A plan is generally considered acceptable if it 
fulfills minimum requirements for tumour and OARs, while 
significant further improvement of the dose distribution is 
considered infeasible (within the allotted time). On top of 
the high workload, the current planning approach leads to 
suboptimal plan quality: the quality is strongly dependent on 
the skills and experience of the planner (operator 
dependence), plan quality is dependent on allotted time, and 
quality is dependent on subjective preferences and priorities 
of the planner and the treating physician. Can this variability 
be reduced? Can treatment planning be standardised? Can we 
guarantee that each patient will be treated with an 
individualised, clinically highly favourable (best) treatment 
plan when generated in an efficient manner? In this 
presentation, data will be provided demonstrating difficulties 
that clinicians encounter in evaluating treatment plans. 
Furthermore, the concept of automated treatment plan 
generation will be discussed as a procedure that may be used 
to standardise treatment planning. Examples of the positive 
impact on plan quality will be presented and consequences 
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Delineation of targets and normal tissues, typically 
performed on CT and/or MR images, is still one of the largest 
sources of variability in radiation therapy treatment plans. In 
fact, despite well-described guidelines for manual 
contouring, substantial intra and inter-observer variations 
exist. Moreover manual contouring is a time consuming 
process that, depending on the number and complexity of 
contours to be delineated, can hinder the implementation of 
adaptive radiotherapy approach. Current perspectives on 
contouring procedure suggest that an automated approach 
could reduce both the contouring time and inter-observer 
variations. Studies evaluating automated contouring in 
multiple disease sites have in fact demonstrated the 
potential to improve efficiency and variability associated 
with manual segmentation. In practice, automated contour 
are carried out using atlas-based, model-based or hybrid 
approaches. In atlas-based segmentation the CT scan of a 
new patient is segmented using segmented scans of one 
(single-patient) or more (multi-patient) previously treated 
patients, called atlases. Methods based on classical 
deformable models use local image features and 
automatically adapts the model shape to fit patient’s organ. 
Various implementations of these two principal methods are 
described in the literature and are available in commercial 
contouring software. Prior their clinical use automated 
contouring methods need an accurate validation. This is a 
challenging task as medical image segmentation lacks a 
known gold standard in its real world application. Phantoms 
as well as synthetic images provide an easily identifiable 
ground truth but are an unrealistic surrogate for patient 
imaging. Moreover, evaluation methods have also lacked 
consensus as to comparison metrics. A number of different 
methods have been utilized for comparing segmentation 
results. The common metrics used fall into one of two 
categories: volume based or distance based. Each of the 
comparison metrics has limitations and thus it is desirable to 
use multiple metrics where possible. This presentation will 
discuss the advantage in standardization deriving from the 
use of automatic contouring and the different approach 
followed in the implementation and validation of automated 
segmentation tools in different anatomical districts.  
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Standardisation of clinical practice is essential for the 
delivery of safe, accurate radiotherapy treatments. 
Implementation of new standards can be at both local and 
national levels and examples of these approaches, from an 
RTT perspective, will be discussed. New standards should be 
developed and implemented within a multi-professional team 
setting. Each profession has a role to play and bring different 
perspectives to the development and implementation 
process. 
Development of training and competency assessments for the 
use of new delivery techniques are an essential aspect of 
implementing any new standards. These assessments can be 
established locally using national guidelines. For example the 
UK National Radiotherapy Implementation Group IGRT 
recommendations1 which was written by a multi-profession 
team to assist centres in utilising IGRT equipment and details 
content for IGRT training and competency assessment 
programmes. This recommendation document has been 
instrumental in the UK with ensure appropriate utilisation of 
IGRT for each anatomical site and ensuring quality IGRT is 
delivered to patients. RTTs are also involved in the 
preparation of national SABR guidelines, as part of the UK 
SABR consortium, particularly focusing on the treatment 
delivery and IGRT sections. 
Clinical trials provide a controlled environment where new 
standards can be developed in a quality assured way. A UK 
prostate radiotherapy clinical trial utilised both IMRT and 
IGRT within the context of a study evaluating a number of 
fractionation schedules. This assisted the centres involved to 
develop IMRT and IGRT standards within their departments 
within a quality assured clinical trial. RTTs were able to use 
IGRT processes clearly defined within the protocol and the 
support of the QA team for the trial were available for advice 
